
2-Methylpropanoic acid 4-methylphenyl ester | CAS:103-93-5
2-Methylpropanoic acid 4-methylphenyl ester
- Name:2-Methylpropanoic acid 4-methylphenyl ester
- CAS:103-93-5
- Synonyms:p-Cresyl isobutyrate; p-Methylphenyl isobutyrate; p-Tolyl isobutyrate
- Molecular Formula:C11H14O2
- Molecular Weight:178.23
- EINESC:203-159-6
Description
Properties
Boiling point | 244 ºC |
---|---|
Flash point | 94 ºC |
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
没有数据 | 没有数据 |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Regulation of cytoplasmic tubulin carboxypeptidase activity in vitro by cations and sulfhydryl-modifying compounds.D R Webster et al.Journal of cellular biochemistry, 60(3), 424-436 (1996-03-01)
Method development and validation for the quantification of organic acids in microbial samples using anionic exchange solid-phase extraction and gas chromatography-mass spectrometry.Simone Heyen et al.Analytical and bioanalytical chemistry, 412(27), 7491-7503 (2020-09-25)
Mechanism of benzylsuccinate synthase: stereochemistry of toluene addition to fumarate and maleate.Chunhua Qiao et al.Journal of the American Chemical Society, 127(24), 8608-8609 (2005-06-16)
Nerve injury evoked loss of latexin expression in spinal cord neurons contributes to the development of neuropathic pain.Hilmar Nils Kühlein et al.PloS one, 6(4), e19270-e19270 (2011-05-17)
Bacterial chemotactic oligopeptides and the intestinal mucosal barrier.D M Ferry et al.Gastroenterology, 97(1), 61-67 (1989-07-01)
[Design, synthesis and hypoglycemic activity of alpha-benzylsuccinic acid derivatives].Ya-lou Wang et al.Yao xue xue bao = Acta pharmaceutica Sinica, 44(5), 491-495 (2009-07-22)
Crystal structure of the complex between carboxypeptidase A and the biproduct analog inhibitor L-benzylsuccinate at 2.0 A resolution.S Mangani et al.Journal of molecular biology, 223(2), 573-578 (1992-01-20)
The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen.I García-Sáez et al.The EMBO journal, 16(23), 6906-6913 (1998-01-31)
Determination of benzylsuccinic acid in gasoline-contaminated groundwater by solid-phase extraction coupled with gas chromatography-mass spectrometry.D E Reusser et al.Journal of chromatography. A, 953(1-2), 215-225 (2002-06-13)
Development and design of specific inhibitors of angiotensin-converting enzyme.D W Cushman et al.The American journal of cardiology, 49(6), 1390-1394 (1982-04-21)
Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors.Natalie A Dales et al.Journal of the American Chemical Society, 124(40), 11852-11853 (2002-10-03)
Metabolic by-products of anaerobic toluene degradation by sulfate-reducing enrichment cultures.H R Beller et al.Applied and environmental microbiology, 58(9), 3192-3195 (1992-09-01)
History of heart failure.Hector O Ventura Congestive heart failure (Greenwich, Conn.), 15(1), 49-49 (2009-02-04)
Cell-free biosynthesis of arphamenine A.A Okuyama et al.Biochemistry international, 12(3), 485-491 (1986-03-01)
Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N.D R Abendschein et al.The Journal of laboratory and clinical medicine, 110(6), 798-806 (1987-12-01)
Affinity chromatographic sorting of carboxypeptidase A and its chemically modified derivatives.L B Cueni et al.Analytical biochemistry, 107(2), 341-349 (1980-09-15)
Redetermination and refinement of the complex of benzylsuccinic acid with thermolysin and its relation to the complex with carboxypeptidase A.A C Hausrath et al.The Journal of biological chemistry, 269(29), 18839-18842 (1994-07-22)
Effect of benzyl succinate on insulin receptor function and insulin action in skeletal muscle: further evidence for a lack of spare high-affinity insulin receptors.A Gumà et al.Molecular and cellular endocrinology, 91(1-2), 29-33 (1993-02-01)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!